CORDIS
EU research results

CORDIS

English EN
Smart integrated biodiagnostic systems for healthcare

Smart integrated biodiagnostic systems for healthcare

Objective

Driven by clinical applications and MNT and IST technology, SmartHEALTH will develop an open integrated architecture for new biodiagnostic systems to support European companies exploiting bioassays or new application concepts. Initial system has a disposable fluidic cartridge with a desktop basestation linking to the ambient eHealth environment - health cards, patient data, online services. This concept will be miniaturised and cost engineered into a portable and consumer product. It will perform multianalyate sensing and interpretation, for nucleic acids, proteins and others and will handle multiple biological sample types.

Results will be interpreted and presented using bioinformatics. Systems will be healthcare user identity and ambient environment aware, respecting confidentiality and information access rights. The IP will enable enhanced medical diagnosis, leading to earlier and more precise results contributing to an increased quality of life as well as increasing the competitiveness of the European IVD sector. The IP will include: selection of probes, sample preparation, fluid handling, concentration, filtering; sensors and transducers, (label free systems and rapid nucleic acid detection systems); surface modification/integration of nanoscale elements; system development - controllers, actuators, data processing, communications and integration with ambient intelligence, on-line information services; understanding of fit to healthcare, input to medical management - user factors, costs, approvals, regulations, ethics.

Clinical areas are in Cancer Diagnostics - breast cancer recurrence monitoring, cervical cancer case finding, colorectal cancer - diagnostic/theranostic/prognostics. Each application includes clinical validation and commercial exploitation partners. The consortium is a powerful set of 3 Universities, 9 Research Institutions, 10 SMEs, 4 larger Companies and 4 Clinical Groups covering all the relevant issues.

Coordinator

THE UNIVERSITY OF NEWCASTLE UPON TYNE

Address

6 Kensington Terrace
Ne1 7ru Newcastle Upon Tyne

United Kingdom

Administrative Contact

Participants (30)

Sort alphabetically

Expand all

CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT

Switzerland

CHARITE-UNIVERSITATSMEDIZIN BERLIN

Germany

DUBLIN CITY UNIVERSITY

Ireland

FORSCHUNGSZENTRUM KARLSRUHE GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG

Germany

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

FRIEDRICH-SCHILLER-UNIVERSITAET JENA

Germany

FUJIREBIO DIAGNOSTICS AB

Sweden

FUNDACION GAIKER

Spain

FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS

Spain

HOSPITAL DE CRUCES

Spain

HOSPITAL DONOSTIA

Spain

IKERLAN S. COOP

Spain

INSTITUT FUER MIKROTECHNIK MAINZ GMBH

Germany

INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM VZW

Belgium

IXSCIENT LIMITED

United Kingdom

MICROFLUIDIC CHIPSHOP GMBH

Germany

MINIFAB (AUST) PTY LTD

Australia

MULTID ANALYSES AB

Sweden

NETHERLANDS ORGANISATION FOR APPLIED SCIENTIFIC RESEARCH - TNO

Netherlands

OLIVETTI I - JET S.P.A.

Italy

OSAKIDETZA

Spain

SINTEF - STIFTELSEN FOR INDUSTRIELL OG TEKNISK FORSKNING VED NORGES TEKNISKE HOEGSKOLE

Norway

TATAA BIOCENTER AB

Sweden

TELECOM ITALIA SPA

Italy

THE NEXUS ASSOCIATION

Switzerland

UNDEFINED

UNIVERSIDAD ROVIRA I VIRGILI

Spain

UNIVERSITÀ DEGLI STUDI DI TRENTO

Italy

WTC, WICHT TECHNOLOGIE CONSULTING - DR. HENNING WICHT

Germany

ZARLINK SEMICONDUCTOR LIMITED

United Kingdom

Project information

Grant agreement ID: 016817

  • Start date

    1 December 2005

  • End date

    30 November 2009

Funded under:

FP6-NMP

  • Overall budget:

    € 21 522 204

  • EU contribution

    € 12 298 210

Coordinated by:

THE UNIVERSITY OF NEWCASTLE UPON TYNE

United Kingdom